Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date

Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date

Michael G McCusker,1 Dennis Orkoulas-Razis,2 Ranee Mehra1 1University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; 2Department of Internal Medicine, University of Maryland Medical Center, Baltimore, MD, USACorrespondence: Ranee MehraUniversity of Maryland M...

Full description

Bibliographic Details
Main Authors: McCusker MG, Orkoulas-Razis D, Mehra R
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:OncoTargets and Therapy
Subjects:
head and neck cancer
immunotherapy
pembrolizumab
checkpoint inhibitors
Online Access:https://www.dovepress.com/potential-of-pembrolizumab-in-metastatic-or-recurrent-head-and-neck-ca-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/potential-of-pembrolizumab-in-metastatic-or-recurrent-head-and-neck-ca-peer-reviewed-article-OTT

Similar Items